How to Get AndroGel in South Carolina

At a glance
- Drug / AndroGel (testosterone gel 1% and 1.62%), FDA-approved Schedule III controlled substance
- Indication / diagnosed male hypogonadism with serum total testosterone below 300 ng/dL on two morning draws
- Telehealth prescribing in SC / legally permitted for testosterone under South Carolina telehealth statute
- Compounding option / licensed 503A pharmacies in South Carolina may dispense compounded testosterone gel
- SC Medicaid coverage / not covered for male hypogonadism as of 2025
- Typical time to first dose / 3 to 7 days from initial consult through prescription fill
- Prescribers allowed / MD, DO, NP (with prescriptive authority), PA (with collaborative agreement)
- Standard dosing / 40.5 mg to 81 mg applied once daily to shoulders or upper arms
What AndroGel Is and Why South Carolina Men Need a Prescription for It
AndroGel is a hydroalcoholic testosterone gel manufactured by AbbVie. It delivers exogenous testosterone transdermally in two concentrations: 1% (delivering 25 mg or 50 mg per pump or packet) and 1.62% (delivering 20.25 mg or 40.5 mg per actuation). The FDA approved the 1% formulation in February 2000 and the 1.62% formulation in May 2011, both for adult males with primary or hypogonadotropic hypogonadism. The current FDA prescribing information is available through the FDA Drugs@FDA database.
Testosterone is a Schedule III controlled substance under the federal Controlled Substances Act. That classification means no physician, nurse practitioner, or physician assistant in South Carolina can legally prescribe it without a valid patient-prescriber relationship, a clinical diagnosis supported by laboratory data, and a DEA registration. Telehealth prescribing of controlled substances in South Carolina requires the prescriber to hold an active South Carolina controlled-substances license in addition to their DEA registration.
Hypogonadism is far from rare. A 2006 study of 2,162 men published in the International Journal of Clinical Practice estimated a prevalence of 38.7% in men aged 45 and older seen in primary care settings, though diagnostic thresholds vary by guideline. The American Urological Association 2018 guideline defines biochemical hypogonadism as a total testosterone below 300 ng/dL confirmed on at least two separate morning blood draws. The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states: "We recommend making a diagnosis of androgen deficiency only in men with consistent symptoms and signs and unequivocally low serum testosterone levels."
Without meeting that diagnostic bar, no licensed prescriber in South Carolina should write for AndroGel, and no South Carolina pharmacy should fill it.
The Step-by-Step Process to Get AndroGel in South Carolina
Getting AndroGel in South Carolina follows four sequential steps: lab work, clinical evaluation, prescription issuance, and pharmacy fulfillment. Each step has specific requirements under South Carolina law and federal controlled-substances regulations.
Step 1. Order or obtain baseline labs. Before any prescriber schedules a clinical evaluation, you need serum total testosterone drawn between 7:00 a.m. and 10:00 a.m. on two separate days. Results from a national reference lab (Quest Diagnostics or LabCorp, both operating collection sites across South Carolina) are accepted by telehealth and in-person providers alike. Additional baseline panels typically include luteinizing hormone (LH), follicle-stimulating hormone (FSH), sex hormone-binding globulin (SHBG), complete blood count (CBC), comprehensive metabolic panel (CMP), prostate-specific antigen (PSA) for men 40 and older, and hematocrit. The Endocrine Society guideline specifies that hematocrit above 54% is a contraindication to initiating testosterone therapy.
Step 2. Schedule a clinical evaluation. You may see a primary care physician, internist, endocrinologist, urologist, or licensed telehealth provider. The visit involves a symptom review (Aging Males' Symptoms scale or similar), a review of your lab results, a discussion of contraindications (prostate cancer, breast cancer, untreated severe sleep apnea, hematocrit >54%), and a shared decision about treatment. South Carolina telehealth law permits synchronous audio-video visits to satisfy the patient-prescriber relationship requirement for Schedule III controlled substances.
Step 3. Receive and transmit the prescription. AndroGel prescriptions in South Carolina must be transmitted electronically under South Carolina's e-prescribing mandate, which took effect January 1, 2022, for controlled substances. Paper prescriptions are still permitted in specific exemption categories, but electronic prescribing to retail pharmacies is the standard pathway. Telehealth platforms transmit directly to your chosen pharmacy.
Step 4. Fill at a retail or 503A compounding pharmacy. South Carolina has multiple retail pharmacy chains (CVS, Walgreens, Rite Aid, and independent pharmacies) that stock brand-name AndroGel. Licensed 503A compounding pharmacies in South Carolina may also prepare testosterone gel in custom concentrations (commonly 10% or 20% for smaller application volumes) on a patient-specific basis, which may reduce cost significantly.
Telehealth Prescribing of AndroGel in South Carolina
Telehealth is a fully legal and increasingly common pathway for AndroGel in South Carolina. The South Carolina Telehealth Alliance operates under S.C. Code Ann. Section 40-47-37, which requires audio-video capability for the initial prescribing encounter for controlled substances. Text-only or asynchronous encounters do not satisfy this requirement for Schedule III drugs.
A licensed telehealth provider must hold an active South Carolina medical license and a DEA registration with a South Carolina address on file. Several national TRT telehealth platforms have South Carolina-licensed prescribers on staff and can complete the full evaluation, transmit the prescription electronically, and coordinate shipping from a partner pharmacy in a single workflow. Typical turnaround from initial video consult to prescription-in-hand is 3 to 7 business days, assuming labs are already available.
The HealthRX clinical team uses a five-criterion checklist before approving AndroGel through its telehealth pathway for South Carolina patients:
- Two morning total testosterone draws below 300 ng/dL, collected on separate days.
- Hematocrit below 54% confirmed on CBC.
- PSA below 4.0 ng/mL (or a documented urology clearance for values between 3.0 and 4.0 in men over 50).
- No active or suspected prostate or breast cancer.
- Documented symptoms consistent with hypogonadism: fatigue, reduced libido, erectile dysfunction, reduced muscle mass, or depressed mood persisting for at least three months.
Meeting all five criteria allows same-visit prescription approval under the HealthRX protocol. Patients missing one criterion receive a targeted workup order rather than an automatic denial.
Lab Work Required Before AndroGel in South Carolina
Lab requirements are not arbitrary. They exist because testosterone therapy carries measurable risks that baseline data help stratify. The Endocrine Society 2018 guideline and the American Urological Association 2018 white paper on testosterone deficiency align on a core pre-treatment panel.
Required before prescribing:
- Serum total testosterone (two morning draws, at least one week apart)
- LH and FSH (to classify primary vs. secondary hypogonadism)
- CBC with hematocrit
- PSA (men 40 and older, or younger with family history of prostate cancer)
- Comprehensive metabolic panel
Recommended but not universally mandated:
- Free testosterone or calculated free testosterone (especially if SHBG is suspected to be elevated, such as in obesity or liver disease)
- Prolactin (to screen for pituitary adenoma in secondary hypogonadism)
- Estradiol (baseline for monitoring during therapy)
- Lipid panel
South Carolina Quest and LabCorp sites do not require a physician order in all circumstances. Several direct-to-consumer lab platforms (such as Ulta Lab Tests and Walk-In Lab) operate collection centers at partnered South Carolina sites and allow patients to order the testosterone panel independently before their telehealth visit, shortening the overall intake timeline.
The T-Trials, a coordinated set of seven randomized placebo-controlled trials in 788 men aged 65 and older with total testosterone below 275 ng/dL, demonstrated that testosterone treatment for one year produced significant improvements in sexual function, bone mineral density, and anemia compared to placebo. The primary T-Trials results were published in the New England Journal of Medicine in 2016 (N=788). Those data support the rationale for screening and treating hypogonadism systematically rather than empirically.
Who Can Prescribe AndroGel in South Carolina
South Carolina law permits multiple prescriber types to write for AndroGel, provided they carry the appropriate licenses and a DEA registration for Schedule III substances.
Medical doctors (MD) and doctors of osteopathic medicine (DO) may prescribe independently. No collaborative agreement is required.
Nurse practitioners (NP) in South Carolina operate under a collaborative agreement with a supervising physician during the first 45 days of their prescriptive authority; after that period, full prescriptive authority including Schedule III controlled substances is available to NPs who hold a South Carolina Controlled Substances License. South Carolina moved to full practice authority for NPs in 2023, which expanded telehealth prescribing capacity for testosterone significantly.
Physician assistants (PA) prescribe under a supervision agreement with a collaborating physician. PAs may prescribe Schedule III controlled substances in South Carolina with appropriate DEA registration and a documented supervision agreement on file with the South Carolina Board of Medical Examiners.
Dentists and optometrists do not have scope to prescribe testosterone. Naturopathic doctors are not licensed prescribers in South Carolina under state law.
When choosing a telehealth provider, confirm that the prescriber's South Carolina license is active by searching the South Carolina Department of Labor, Licensing and Regulation (SCLLR) Licensee Search portal before the appointment.
AndroGel Pharmacy Options in South Carolina
Once a prescription is in hand, South Carolina residents have three main fulfillment channels.
Retail chain pharmacies. CVS, Walgreens, and Walmart pharmacies across South Carolina carry brand-name AndroGel 1% and 1.62%. Without insurance, the cash price for AndroGel 1.62% (2-pump/day, 30-day supply) ranges from approximately $380 to $520 at retail. The AbbVie patient savings card may reduce out-of-pocket cost for commercially insured patients to $0 to $10 per month, subject to eligibility restrictions.
503A compounding pharmacies. A 503A compounding pharmacy in South Carolina prepares testosterone gel on a patient-specific, prescription-only basis. Compounded testosterone gel (typically at 10% or 20% concentration in a Lipoderm or PLO base) costs approximately $40 to $80 for a 30-day supply at most South Carolina 503A pharmacies. The FDA does not approve compounded formulations, and they are not interchangeable with FDA-approved AndroGel. The South Carolina Board of Pharmacy licenses and inspects 503A compounding pharmacies; verify licensure at the SCLLR portal before filling.
Mail-order specialty pharmacies. Several telehealth TRT platforms ship testosterone gel to South Carolina addresses from out-of-state 503A or retail pharmacies. South Carolina accepts out-of-state pharmacy shipments provided the dispensing pharmacy holds an active South Carolina non-resident pharmacy permit issued by the South Carolina Board of Pharmacy.
Insurance and Prior Authorization for AndroGel in South Carolina
Brand-name AndroGel is covered by many South Carolina commercial insurance plans, but prior authorization (PA) is almost universally required. South Carolina Medicaid (Healthy Connections) does not cover AndroGel or any form of testosterone gel for male hypogonadism as of January 2025.
A typical South Carolina commercial insurance prior authorization for AndroGel requires:
- Two documented serum total testosterone values below 300 ng/dL drawn before 10:00 a.m.
- ICD-10 diagnosis code E29.1 (testicular hypofunction) or E23.0 (hypopituitarism) on the clinical note.
- Documentation that at least one symptom of hypogonadism is present (reduced libido, fatigue, erectile dysfunction, or loss of muscle mass).
- Prescriber attestation that the patient is an adult male.
- Some payers also require a trial of generic testosterone cypionate injection (the lowest-cost testosterone formulation) before approving the topical gel, invoking a step-therapy clause.
If the PA is denied, South Carolina insurance law (S.C. Code Ann. Section 38-59-240) gives enrollees the right to an internal appeal within 180 days and an independent external review. The prescriber's office handles the appeal with supporting clinical documentation.
Generic testosterone gel (authorized generic or AB-rated generic to AndroGel 1.62%) is available at some South Carolina pharmacies and may not require prior authorization under plans that tier generics favorably. Generic testosterone gel 1.62% cash prices are lower than brand, typically $90 to $160 per 30-day supply without a manufacturer coupon.
Monitoring After Starting AndroGel in South Carolina
Prescribing AndroGel is not a one-time transaction. South Carolina prescribers following Endocrine Society guidelines re-check labs 3 to 6 months after initiation and then annually if values are stable.
Standard follow-up labs include:
- Serum total testosterone (target range: 400 to 700 ng/dL mid-cycle for topical formulations)
- Hematocrit (dose reduction or therapeutic phlebotomy if hematocrit exceeds 54%)
- PSA (discontinue testosterone and refer to urology if PSA rises more than 1.4 ng/mL above baseline in any 12-month period)
- Bone mineral density via DEXA scan at 1 to 2 years in men with osteoporosis at baseline
The T-Trials data showed a statistically significant increase in noncalcified coronary artery plaque volume in the testosterone-treated group vs. placebo (mean change 41 mm³ vs. 18 mm³, P<0.001) over 12 months in a cardiovascular substudy of 138 men. That substudy was published in JAMA in 2017. That finding underscores why monitoring is not optional.
Patients applying AndroGel must be counseled on secondary transfer risk. The FDA added a black-box warning to all testosterone gel products in 2009 after reports of virilization in children who had skin-to-skin contact with treated adults. Application to the inner thigh or genitals, or areas covered by clothing that contacts others, is contraindicated. Washing hands immediately after application and covering the application site with clothing before contact with children or women is required by the FDA labeling.
Transferring an Existing AndroGel Prescription to South Carolina
If you are moving to South Carolina or establishing care with a new provider, a prior AndroGel prescription from another state does not automatically transfer. South Carolina pharmacies require the prescription to originate from a prescriber holding a valid South Carolina DEA registration or to be transferred from a pharmacy in another state provided the dispenser is licensed in South Carolina.
A practical approach: ask your current prescriber to send records (lab results, clinical notes, and prescription history) to a South Carolina-licensed provider who can review and issue a new South Carolina prescription. Most telehealth platforms accept uploaded records and can complete a transfer visit in a single audio-video session. If you have an ongoing supply, a 30-day bridge allows time to complete the new-patient intake without a gap in therapy.
Frequently asked questions
›How do I get an AndroGel prescription in South Carolina?
›What labs are needed before AndroGel in South Carolina?
›Are there telehealth providers in South Carolina prescribing AndroGel?
›How long until I receive AndroGel in South Carolina?
›Can I transfer an AndroGel prescription to South Carolina?
›Are 503A pharmacies in South Carolina licensed to ship testosterone gel?
›Who can prescribe AndroGel in South Carolina: MD vs NP vs PA?
›What documentation does prior authorization require in South Carolina?
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Rosen RC, Araujo AB, Connor MK, et al. The NERI Hypogonadism Screener: psychometric validation in male patients and controls. Clin Endocrinol. 2011;74(2):248-256. https://pubmed.ncbi.nlm.nih.gov/20796000/
- U.S. Food and Drug Administration. AndroGel (testosterone gel) 1% and 1.62% prescribing information. Drugs@FDA. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- U.S. Food and Drug Administration. FDA drug safety communication: FDA cautions about using testosterone products for low testosterone due to aging. 2015. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
- Budoff MJ, Ellenberg SS, Lewis CE, et al. Testosterone treatment and coronary artery plaque volume in older men with low testosterone. JAMA. 2017;317(7):708-716. https://pubmed.ncbi.nlm.nih.gov/28196275/
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
- South Carolina General Assembly. S.C. Code Ann. Section 40-47-37: Telehealth practice standards. https://www.scstatehouse.gov/code/t40c047.php
- Centers for Disease Control and Prevention. Hypogonadism prevalence and testosterone therapy trends. https://www.cdc.gov/